Subtle Medical Inc. raised over $30 million in a Series B+ round led by Samsung Ventures, bringing the total Series B funding to over $30 million.
Subtle Medical Inc. raised over $30 million in a Series B+ round led by Samsung Ventures, bringing the total Series B funding to over $30 million.
07/24/24, 12:29 PM
Location
menlo parkMoney raised
$30 million
Round Type
series b
Investors
Samsung Ventures, Ignite Innovation, Brv Capital, Envision X Capital, Fusion Fund
Subtle Medical Inc. has raised close to $10 million in a Series B+ round, bringing the total Series B funding to over $30 million. The new funding will support further global expansion and new innovations for AI-powered medical imaging technology.
Company Info
Location
menlo park, california, united states
Additional Info
Subtle Medical, Inc. is a healthcare technology company with deep learning solutions that improve workflow efficiency and patient experience. The company has the first AI software solutions FDA-cleared for medical imaging enhancement, SubtlePET™ and SubtleMR™. It was named CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner. Current clinical partners include UCSF, Hoag Hospital, Mt. Sinai, Sickkids, Radnet, DASA, Tiantan Hospital, and Middlesex Hospital, among others. Subtle is currently in collaboration with top-tier medical device vendors, including Siemens Healthineers, GE Healthcare, Philips (China) and several pharmaceutical partners. Subtle was founded in 2017. Seed investors include Bessemer Venture Partners, Zhenfund (Momentor Ventures), Data Collective, Breyer Capital, and Baidu Ventures, among others. For more information, please visit subtlemedical.com or email [email protected].